Learn more →
Back to Expert Scholars
Translational Medicine / 转化医学Tumor Organoid Drug Screening

Calvin Kuo

MD, PhD

🏢Stanford University🌐USA

Maureen Lyles D'Ambrogio Professor of Medicine

68
h-index
0
Key Papers
0
Key Contributions

👥Biography 个人简介

Calvin Kuo developed the air-liquid interface organoid method that preserves native tumor stroma, including immune cells, fibroblasts, and vasculature, enabling physiologically accurate immunotherapy testing in vitro. His organoid-T cell co-culture systems have demonstrated checkpoint inhibitor responses that correlate with clinical outcomes. His technological innovations have made organoids a viable platform for immuno-oncology drug development.

Share:

🧪Research Fields 研究领域

Air-liquid interface organoids
Tumor immune microenvironment modeling
Organoid-T cell co-culture
Native tumor stroma preservation
Immunotherapy testing in organoids

🎓Key Contributions 主要贡献

Representative Works 代表性著作

📄Data Sources 数据来源

Last updated: 2026-04-01 | All information from publicly available academic sources

关注 Calvin Kuo 的研究动态

Follow Calvin Kuo's research updates

留下邮箱,当我们发布与 Calvin Kuo(Stanford University)相关的新研究或访谈时,我们会通知你。

我们不会泄露你的信息,也不会发送无关内容。随时可以退订。

Explore More Experts

Discover the researchers shaping the future of cancer treatment